Abstract:Background Several observational studies have proposed a potential link between gut microbiota and the onset and progression of sepsis. Nevertheless, the causality of gut microbiota and sepsis remains debatable and warrants more comprehensive exploration. Methods We conducted a two-sample Mendelian randomization (MR) analysis to test the causality between gut microbiota and the onset and progression of sepsis. The genome-wide association study (GWAS) summary statistics for 196 bacterial traits were extracted from the MiBioGen consortium, whereas the GWAS summary statistics for sepsis and sepsis-related outcomes came from the UK Biobank. The inverse-variance weighted (IVW) approach was the primary method used to examine the causal association. To complement the IVW method, we utilized four additional MR methods. We performed a series of sensitivity analyses to examine the robustness of the causal estimates. Results We assessed the causality of 196 bacterial traits on sepsis and sepsis-related outcomes. Genus Coprococcus2 [odds ratio (OR) 0.81, 95% confidence interval (CI) (0.69–0.94), p = 0.007] and genus Dialister (OR 0.85, 95% CI 0.74–0.97, p = 0.016) had a protective effect on sepsis, whereas genus Ruminococcaceae UCG011 (OR 1.10, 95% CI 1.01–1.20, p = 0.024) increased the risk of sepsis. When it came to sepsis requiring critical care, genus Anaerostipes (OR 0.49, 95% CI 0.31–0.76, p = 0.002), genus Coprococcus1 (OR 0.65, 95% CI 0.43–1.00, p = 0.049), and genus Lachnospiraceae UCG004 (OR 0.51, 95% CI 0.34–0.77, p = 0.001) emerged as protective factors. Concerning 28-day mortality of sepsis, genus Coprococcus1 (OR 0.67, 95% CI 0.48–0.94, p = 0.020), genus Coprococcus2 (OR 0.48, 95% CI 0.27–0.86, p = 0.013), genus Lachnospiraceae FCS020 (OR 0.70, 95% CI 0.52–0.95, p = 0.023), and genus Victivallis (OR 0.82, 95% CI 0.68–0.99, p = 0.042) presented a protective effect, whereas genus Ruminococcus torques group (OR 1.53, 95% CI 1.00–2.35, p = 0.049), genus Sellimonas (OR 1.25, 95% CI 1.04–1.50, p = 0.019), and genus Terrisporobacter (OR 1.43, 95% CI 1.02–2.02, p = 0.040) presented a harmful effect. Furthermore, genus Coprococcus1 (OR 0.42, 95% CI 0.19–0.92, p = 0.031), genus Coprococcus2 (OR 0.34, 95% CI 0.14–0.83, p = 0.018), and genus Ruminiclostridium6 (OR 0.43, 95% CI 0.22–0.83, p = 0.012) were associated with a lower 28-day mortality of sepsis requiring critical care. Conclusion This MR analysis unveiled a causality between the 21 bacterial traits and sepsis and sepsis-related outcomes. Our findings may help the development of novel microbiota-based therapeutics to decrease the morbidity and mortality of sepsis.

Circulating inflammatory cytokines and the risk of sepsis: a bidirectional mendelian randomization analysis

Causal associations between circulating cytokines and risk of sepsis and related outcomes: a two-sample Mendelian randomization study

The causal effects of circulating cytokines on sepsis: a Mendelian randomization study

The Relationship between Circulating Immune Cell Phenotypes and Sepsis: A Mendelian Randomization Study

Gut microbiota, circulating inflammatory proteins and sepsis: a bi-directional Mendelian randomization study

Genetic Insights into Sepsis: Mendelian Randomization Analysis of Cerebrospinal Fluid Metabolites

Dissecting the mediating role of cytokines in the interaction between immune traits and sepsis: insights from comprehensive mendelian randomization

Using Mendelian randomization provides genetic insights into potential targets for sepsis treatment

[Causal association between immune cells and sepsis: a based on Mendelian randomization method study]

Circulating micronutrient levels and their association with sepsis susceptibility and severity: a Mendelian randomization study

Genetic associations between autoimmune diseases and the risks of severe sepsis and 28-day mortality: a two-sample Mendelian randomization study

Circulating levels of cytokines and risk of cardiovascular disease: a Mendelian randomization study

Dissecting the mediating role of inflammatory factors in the interaction between metabolites and sepsis: insights from bidirectional Mendelian randomization

The causality of gut microbiota on onset and progression of sepsis: a bi-directional Mendelian randomization analysis

Causal effects of gut microbiota on sepsis and sepsis-related death: insights from genome-wide Mendelian randomization, single-cell RNA, bulk RNA sequencing, and network pharmacology

Unveiling the Causal Association between Non-Infectious Respiratory Disorders and Sepsis through Mendelian Randomization Analysis

Gut microbiota and sepsis: bidirectional Mendelian study and mediation analysis

Plasma Proteome, Metabolome Mendelian Randomization Identifies Sepsis Therapeutic Targets

Genetic causal association between gut microbiota and sepsis: Evidence from a two-sample bidirectional Mendelian randomization analysis

Genetically Determined Circulating Levels of Cytokines and the Risk of Rheumatoid Arthritis

Gut microbiota and sepsis and sepsis-related death: a Mendelian randomization investigation